3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
5
Breast Neoplasms
3
Neoplasm Metastasis
2
Leukemia, B-Cell
2
Urinary Bladder Neoplasms
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hyperparathyroidism, Primary
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Carcinoma, Renal Cell
1
Carcinoma
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Celecoxib
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
Tablets
×
Clear all
No trials found.